Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intentional Segmentectomy for Clinical T1 N0 Non-small Cell Lung Cancer: Survival Differs by Segment

The Annals of Thoracic Surgery(2020)10.1016/j.athoracsur.2020.05.166Source: DataRank Database

Intentional Segmentectomy for Clinical T1 N0 Non-small Cell Lung Cancer: Survival Differs by Segment is a research paper published in The Annals of Thoracic Surgery (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.32)OA: bronzeTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Raul Caso,Giye Choe,Kay See Tan ORCID,James G. Connolly ORCID,Joseph Dycoco ORCID

Live enrichment

PubMed:32739257 PMC:PMC8170548 OpenAlex:https://openalex.org/W3046144649

National Cancer Institute

Grant: P30-CA-008748

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: T32 CA009501

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

FWCI

1.32

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier TDM

journalhttp://www.annalsthoracicsurgery.org/article/S0003497520312236/pdf

publisherhttp://www.annalsthoracicsurgery.org/article/S0003497520312236/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0003497520312236?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0003497520312236?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.athoracsur.2020.05.166

Fields of Study

Lung Cancer Diagnosis and TreatmentLung Cancer Research StudiesRadiomics and Machine Learning in Medical Imaging03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedCarcinoma, Non-Small-Cell LungFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingNew YorkPneumonectomyRetrospective StudiesTime FactorsSurvival RateTreatment OutcomeDisease-Free SurvivalPropensity Score

Keywords

MedicineLymphovascular invasionHazard ratioConfidence intervalResection marginLung cancerStage (stratigraphy)Proportional hazards modelAdjuvant therapySurgeryInternal medicineCancerMetastasisResectionMaleLung NeoplasmsTime FactorsNew YorkMiddle AgedDisease-Free SurvivalSurvival RateTreatment OutcomeCarcinoma, Non-Small-Cell LungHumansFemalePneumonectomyPropensity ScoreAgedFollow-Up StudiesNeoplasm StagingRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being